DURACILLIN A.S. Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Duracillin A.s., and when can generic versions of Duracillin A.s. launch?
Duracillin A.s. is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in DURACILLIN A.S. is penicillin g procaine. There is one drug master file entry for this compound. Additional details are available on the penicillin g procaine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Duracillin A.s.
A generic version of DURACILLIN A.S. was approved as penicillin g procaine by KING PHARMS LLC on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DURACILLIN A.S.?
- What are the global sales for DURACILLIN A.S.?
- What is Average Wholesale Price for DURACILLIN A.S.?
Summary for DURACILLIN A.S.
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 35 |
| Patent Applications: | 371 |
| DailyMed Link: | DURACILLIN A.S. at DailyMed |
US Patents and Regulatory Information for DURACILLIN A.S.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | DURACILLIN A.S. | penicillin g procaine | INJECTABLE;INJECTION | 060093-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
